pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
1,831
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 1
SOT-201
Solid Tumor
SOTIO Biotech AS
0
catalysts
Phase 1
SPX-303
Solid Tumor
$SHGI
Sparx Holdings Group, Inc.
0
catalysts
Preclinical
SPX-306
Unspecified Cancer
$SHGI
Sparx Holdings Group, Inc.
0
catalysts
Preclinical
← prev
page 34 of 62
next →
131
Pain
89
Neurology
1
SPX-308
Unspecified Cancer
$SHGI
Sparx Holdings Group, Inc.
0
catalysts
Preclinical
SPX-602
Unspecified Cancer
$SHGI
Sparx Holdings Group, Inc.
0
catalysts
Preclinical
SPX-608
Unspecified Cancer
$SHGI
Sparx Holdings Group, Inc.
0
catalysts
Preclinical
SPX-629
Unspecified Cancer
$SHGI
Sparx Holdings Group, Inc.
0
catalysts
Preclinical
SRC-3KO Treg Adoptive Cell Therapy
Glioblastoma Multiforme (GBM)
CoRegen Inc
0
catalysts
Preclinical
SRC-3KO Treg Allogeneic Cell Therapy
Solid Tumor
CoRegen Inc
0
catalysts
Phase 1
ST-01156
Bile Duct Cancer (Cholangiocarcinoma)
Seed Therapeutics Inc
0
catalysts
Phase 2
ST316
Metastatic Bile Duct Cancer
Sapience Therapeutics Inc
0
catalysts
Phase 2
STK-012
Non-Small Cell Lung Cancer
Synthekine Inc
0
catalysts
Preclinical
STP-355
Breast Cancer
Sirnaomics Ltd
0
catalysts
Preclinical
STP-369
Head And Neck Cancer
Sirnaomics Ltd
0
catalysts
Phase 1
STP-707
Colorectal Cancer
Sirnaomics Ltd
0
catalysts
Phase 1
STRO-004
Cervical Cancer
$STRO
SUTRO BIOPHARMA, INC.
0
catalysts
Phase 2
STX-001
Melanoma
Strand Therapeutics Inc
0
catalysts
Phase 2
SV-102
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Syncromune Inc
0
catalysts
Phase 1
SW-682
Malignant Mesothelioma
SpringWorks Therapeutics Inc
0
catalysts
Phase 2
SY-102
Refractory Multiple Myeloma
Syena
0
catalysts
Preclinical
SYD-003
Pancreatic Cancer
Synovo GmbH
0
catalysts
Phase 1
SYN-125
Epithelial Tumor
Synermore Biologics Co Ltd
0
catalysts
Phase 2
SYS-6002
Cervical Cancer
$CRBP
Corbus Pharmaceuticals Holdings, Inc.
0
catalysts
Preclinical
Second Shared Cell Therapy
Unspecified Cancer
$ADPT
Adaptive Biotechnologies Corp
0
catalysts
Preclinical
Small Molecule for Glioblastoma
Nano Quercetin
Glioblastoma Multiforme (GBM)
Cancer Research and Life Foundation
0
catalysts
Preclinical
Small Molecule for Multiple Myeloma
Multiple Myeloma (Kahler Disease)
Sino-American Cancer Foundation
0
catalysts
Preclinical
Small Molecule for Osteosarcoma
Osteosarcoma
K-Group Beta Inc
0
catalysts
Preclinical
Small Molecule to Inhibit FGL2 for Glioblastoma Multiforme
Glioblastoma Multiforme (GBM)
University of Texas MD Anderson Cancer Center
0
catalysts
Preclinical
Small Molecule to Inhibit MAPK13 and MAPK14 for Breast Cancer and Respiratory Disease
Asthma
NuPeak Therapeutics Inc
0
catalysts
Preclinical
Small Molecule to Inhibit Monoamine Oxidase Type A for Glioma
Glioma
University of Southern California
0
catalysts
